NL-OMON35371已完成不适用
Detection of recurrent head and neck squamous cell carcinomas with DW-MRI after (chemo)radiation - DW-MRI in HNSCC after (chemo)radiation
niversitair Medisch Centrum Utrecht0 个研究点目标入组 74 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 74
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients with clinical suspicion of local recurrence after treated for laryngeal- hypopharyngeal- or oropharyngeal squamous cell carcinoma with (chemo)radiation.
- •Primary (chemo)radiation for the primary tumour region
- •Last radiotherapy: > 2 months and < 3 years
- •*Informed consent* signed by patient
- •Age * 18 years
排除标准
- •Patient with contraindication of MRI or contrast agent as defined in the protocols of the radiology department of the UMCU
- •Patients with primary salvage surgery for the primary lesion
- •Patients whom recurrence is obvious that no additional imaging confirmation is necessary for the decision to take biopsies.
研究者
相似试验
招募中
不适用
Detection of recurrent head and neck tumours after chemoradiation with a tumor-sensitive MRI technique.squamous cell carcinoma, recurrence, radiotherapyplaveiselcelcarcinoom, recidief, radiotherapieNL-OMON29514niversity Medical Center Utrecht (UMCU), Department if ENT75
已完成
不适用
outcomes of Head and neck cancer in HIV and Hepatitis B & C patients.CTRI/2018/04/012911A156
尚未招募
1 期
A Pilot Study of Cetuximab Radiolabelled with Gallium-68, Lutetium-177 or Rhenium-188 as a Novel Radioimmunotherapy for Advanced Head and Neck Cancer: A New Adjunct to Multi-modality Treatment.Head and Neck Squamous Cell CarcinomaCancer - Head and neckACTRN12614000491662Dr Timothy Marr30
已完成
不适用
Human papilloma virus on head and neck squamous cell carcinomasHead and neck carcinomasJPRN-UMIN000002086Shigeru Hirano40
尚未招募
不适用
The Impact of Combined Modality Therapy on Sensorineural Hearing Loss in Patients with Head and Neck CancerSensorineural Hearing LossACTRN12615001300561Phoebe Shorter100